Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Champions Oncology Inc

CSBR
Current price
5.06 USD -0.04 USD (-0.78%)
Last closed 5.07 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 67 969 000 USD
Yield for 12 month -1.56 %
1Y
3Y
5Y
10Y
15Y
CSBR
21.11.2021 - 28.11.2021

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey. Address: One University Plaza, Hackensack, NJ, United States, 07601

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6 USD

P/E ratio

Dividend Yield

Current Year

+53 870 000 USD

Last Year

+49 109 000 USD

Current Quarter

+12 019 000 USD

Last Quarter

+11 573 000 USD

Current Year

+24 338 000 USD

Last Year

+25 477 000 USD

Current Quarter

+4 170 000 USD

Last Quarter

+4 955 000 USD

Key Figures CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 335 000 USD
Operating Margin TTM -21.44 %
PE Ratio
Return On Assets TTM -17.48 %
PEG Ratio
Return On Equity TTM -388.65 %
Wall Street Target Price 6 USD
Revenue TTM 49 224 000 USD
Book Value -0.15 USD
Revenue Per Share TTM 3.63 USD
Dividend Share
Quarterly Revenue Growth YOY -5.9 %
Dividend Yield
Gross Profit TTM 24 338 000 USD
Earnings Share -0.72 USD
Diluted Eps TTM -0.72 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -28.6 %
Profit Margin -19.76 %

Dividend Analytics CSBR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:12
Payout Ratio
Last Split Date 12.08.2015
Dividend Date

Stock Valuation CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 22.8833
Enterprise Value Revenue 1.4473
Price Sales TTM 1.3808
Enterprise Value EBITDA -10.4677
Price Book MRQ 6.7705

Financials CSBR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CSBR

For 52 weeks

4.17 USD 7.32 USD
50 Day MA 5.5 USD
Shares Short Prior Month 62 578
200 Day MA 5.87 USD
Short Ratio 10.69
Shares Short 58 061
Short Percent 0.84 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds


M

MDAXEX

207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics